Shire Divests Oncology Products to Servier
By Natasha Piper
Pharma Deals Review: Vol 2018 Issue 5 (Table of Contents)
Published: 4 May-2018
DOI: 10.3833/pdr.v2018.i5.2323 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Shire has agreed to sell its oncology business to Servier amidst takeover negotiations with Takeda Pharmaceutical...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS